164 related articles for article (PubMed ID: 37171330)
1. A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis.
Xing T; Hu Y; Wang H; Zou Q
Medicine (Baltimore); 2023 May; 102(19):e33739. PubMed ID: 37171330
[TBL] [Abstract][Full Text] [Related]
2. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.
Du F; Zheng F; Han Y; Zhao J; Yuan P
Front Pharmacol; 2022; 13():820437. PubMed ID: 35721151
[No Abstract] [Full Text] [Related]
3. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma.
Feng J; Fu F; Nie Y
Front Pharmacol; 2023; 14():1121634. PubMed ID: 36925638
[No Abstract] [Full Text] [Related]
5. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
6. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer.
Li J; Gao F; Su J; Pan T
Medicine (Baltimore); 2023 May; 102(19):e33605. PubMed ID: 37171324
[TBL] [Abstract][Full Text] [Related]
8. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
[TBL] [Abstract][Full Text] [Related]
10. Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer.
Liu Y; Ouyang W; Huang H; Tan Y; Zhang Z; Yu Y; Yao H
Front Oncol; 2022; 12():960579. PubMed ID: 36713514
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer.
Zhang XX; Yu X; Zhu L; Luo JH
Medicine (Baltimore); 2023 Nov; 102(46):e35923. PubMed ID: 37986376
[TBL] [Abstract][Full Text] [Related]
12. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Hu W; Li M; Zhang Q; Liu C; Wang X; Li J; Qiu S; Li L
J Ovarian Res; 2021 Aug; 14(1):103. PubMed ID: 34364397
[TBL] [Abstract][Full Text] [Related]
14. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
15. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
16. Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach.
Deng L; Mi J; Ruan X; Zhang G; Pan Y; Wang R
Mediators Inflamm; 2022; 2022():4007469. PubMed ID: 36299414
[TBL] [Abstract][Full Text] [Related]
17. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
18. A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis.
Chen W; Kang Y; Sheng W; Huang Q; Cheng J; Pei S; Meng Y
Front Immunol; 2024; 15():1331841. PubMed ID: 38370403
[TBL] [Abstract][Full Text] [Related]
19. Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma.
Xiang XH; Yang L; Zhang X; Ma XH; Miao RC; Gu JX; Fu YN; Yao Q; Zhang JY; Liu C; Lin T; Qu K
World J Gastroenterol; 2019 Apr; 25(14):1715-1728. PubMed ID: 31011256
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]